Evaluation of the Prognostic Value of Solute Carrier Family 34 Member 2 “SLC34A2” in Papillary Thyroid Carcinoma: An Immunohistochemical Study. This evidence concerns the gene SLC34A2 and thyroid gland papillary carcinoma.